Oliver Wyman is proud to be participating at LSX World Congress on May 10-11, 2022. Join Oliver Wyman's Healthcare and Life Sciences team as they moderate a panel on the topic Business Models For Cell & Gene Therapy: Evolution Or Revolution From The Existing Biopharma Model? Joining them as panelists:
- Olav Hellebo, CEO, ReNeuron
- Jean-Philippe Combal, CEO, Vivet Therapeutics
- Lucas de Breed, Founder, August
- Elisa Petris, Partner, Syncona
Learn more about LSX Congress and how to attend here
The 8th LSX World Congress gathers the founders and CEOs of innovative start-ups through to healthcare giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.
It is an industry-leading gathering with qualified 1:1 partnering at its core, connecting the biotech, healthtech and medtech industry c-suite with the sector’s most active investors, pharma and health technology BD&L teams, R&D leaders, KOLs and top tier service companies who are driving the sector forward.